724 organization(s) found
VCCC Alliance
The VCCC Alliance is Australia’s first and most ambitious comprehensive cancer centre: a joint venture of 12 member and associate member institutions, integrating cancer research, education and clinical care. It comprises research, education and clinical care organisations. The vision of the VCCC Alliance is that this inclusive, innovative and collaborative integration of cancer research, education and patient care will save and improve lives.
VelaVigo
VelaVigo was founded by Dr. Jing Li, a renowned biopharma executive, in October 2021. We leverage discovery as an innovative engine with an emphasis on novel technologies, including bispecific/multi-specific antibodies, ADC, and new modalities. We are committed to building full capabilities that cover the entire value chain of drug discovery and development, including novel discovery technology platforms, translational medicine, CMC, clinical development, and commercialization.
Veracyte
Veracyte's molecular tests provide important information that help_s_ doctors make key decisions that can change the course of each cancer patient�s care and improve outcomes.
Verastem Oncology
Pursuing unexplored pathways demands that were purposeful in everything we do. And it's an endeavor thats only possible with an experienced team of employees and partners dedicated to a singular purpose: changing and improving the way cancer is treated by delivering novel therapies that address areas of high unmet need in RAS pathway-driven cancers. At Verastem, it takes our diversity of backgrounds, expertise, perspectives, and skills to find the answers that patients need but don't have yet.
Violet Pharmaceuticals
Violet Pharmaceuticals is developing groundbreaking mRNA therapies for metastatic cancer patients. Our First-in-Class mRNA therapies are designed to enhance the effectiveness of immunotherapies and target metastatic cancers.
ViVerita Therapeutics
At ViVerita, we develop the next wave of precision therapies by embracing the complexity and heterogeneity of cancer.
Wayfinder Biosciences
Wayfinder�s team of seasoned experts in RNA biophysics, molecular biology and machine learning is dedicated to pioneering RNA-targeting small molecule therapies. Our Scientific Advisory Board is composed of industry leaders in drug discovery and development with a successful history of bringing therapies to the clinic and to the market. Our Mission: Discovering treatments for currently incurable diseases
WEHI (Walter+Eliza Hall Institute of Medical Research)
Where the world’s brightest minds collaborate and innovate to make discoveries that will help us to live healthier for longer.
West China Hospital, Sichuan University – Oncology Dept.
Large university hospital with oncology services; commonly cited in clinical trial registries and as a major oncology centre outside the coastal megacities. (PMC)
Wings of Hope Cancer Support Group – South Africa
Survivor-led support organisation providing patient hospital visits, information meetings, telephonic support and community support for cancer patients.
Women United Against Cancer – South Africa (SAUAC)
SAUAC aims to change the approach toward cancer prevention by advocacy, awareness, early detection campaigns and community education.
Xilio Therapeutics
We envision a brighter future for people living with cancer, where immuno-oncology therapies eliminate cancer at its source without severe systemic side effects.
Yuhan
As a leading global producer and distributor of phar- maceuticals, APIs/ Intermediates and consumer goods, Yuhan promotes shared values, fosters social responsi- bility and partners with like-minded companies for mutual profit and continuing social progress. Yuhan�s vision is to improve the health and well-being of people everywhere by offering high quality, innova- tive, products and supporting social progress.
Yunnan Cancer Hospital
Regional cancer hospital involved in clinical trials, representing cancer-care institutions beyond the major coastal/urban hubs. (CareAcross)